ArticleFrontiers in oncology2026
An interpretable deep learning framework for intestinal metaplasia detection in gastric histopathology images.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intestinal metaplasia (IM) is a precancerous gastric lesion that commonly develops in the setting of chronic gastric inflammation and represents a key step in gastric carcinogenesis. Delayed or inaccurate identification of IM may delay appropriate surveillance and clinical management, potentially increasing the risk of progression to gastric cancer. Methods: In this study, we propose a deep learning-based framework, termed CNXTGeM, for the automated detection of intestinal metaplasia in hematoxylin and eosin (H&E)-stained gastric histopathology images. The model integrates a ConvNeXt-Tiny backbone with Generalized Mean (GeM) pooling and Efficient Channel Attention (ECA) to enhance feature representation and discrimination of histopathological patterns associated with intestinal metaplasia. The framework was evaluated using 1,037 H&E-stained gastric biopsy samples (516 IM and 521 controls) obtained from Elazığ Fethi Sekin City Hospital, with an 80/10/10 stratified patient-level train/validation/test split to prevent data leakage. External validation was further performed using the publicly available GasHisSDB dataset (33,284 image patches). Model interpretability was assessed using three complementary gradient-based visualization techniques: Grad-CAM, Grad-CAM++, and XGrad-CAM. Results: CNXTGeM outperformed the evaluated baseline deep learning models, including VGG16, VGG19, DenseNet121, and MobileNetV2, achieving an accuracy of 99.04%, precision of 98.08%, specificity of 98.11%, and an F1-score of 99.03%. Notably, the proposed framework achieved 100% sensitivity, representing an 8.51% improvement in recall over the baseline ConvNeXt model, which may help reduce missed IM cases in computer-assisted histopathological assessment. On the external GasHisSDB dataset, CNXTGeM maintained robust performance (accuracy = 99.34%, F1-score = 99.31%), suggesting good generalization to an independent external dataset. Gradient-based visualization analyses (Grad-CAM, Grad-CAM++, and XGrad-CAM) indicated that the model consistently focused on histopathological regions relevant to inflammation-related mucosal alterations. Conclusion: The proposed CNXTGeM framework demonstrates the potential to provide a reliable, efficient, and interpretable artificial intelligence-based approach for computer-assisted detection of intestinal metaplasia. By accurately identifying inflammation-associated histopathological features, the model supports computer-assisted histopathological assessment, reduces inter-observer variability, and may facilitate digital pathology workflows for the assessment of intestinal metaplasia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.